BACKGROUND AND PURPOSE: Vasospasm after aneurysmal subarachnoid hemorrhage (SAH) remains a leading cause of death and disability after aneurysm rupture. Decreased availability of nitric oxide (NO) may be crucial in its pathogenesis. We hypothesized that endothelial NO synthase (eNOS) polymorphisms may determine susceptibility to vasospasm in SAH patients. METHODS: We conducted a prospective cohort study of SAH patients and determined vasospasm by cerebral angiography. We genotyped 3 eNOS polymorphisms: an intron 4 variable-number tandem-repeat, a promoter single-nucleotide polymorphism (-786T-->C SNP), and a coding SNP in exon 7 (894G-->T encoding E298D). Using multivariable logistic regression, we quantified the association of eNOS polymorphisms in patients with vasospasm confirmed by cerebral angiography. RESULTS: For the eNOS promoter -786T-->C SNP, the presence of the CC genotype compared with any T genotype (CT or TT) was associated with increased odds of vasospasm (odds ratio=2.97, 95% CI=1.32 to 6.67, P=0.008). No association with vasospasm was observed for the eNOS 894G-->T or variable-number tandem-repeat polymorphisms. CONCLUSIONS: These findings suggest that genetic variation influencing NO regulation contributes to the risk of angiographic vasospasm in patients with SAH. The specific role of the promoter SNP (-786T-->C) may determine the effect of NO regulated by this pathway, distinct from other known eNOS polymorphisms.
BACKGROUND AND PURPOSE:Vasospasm after aneurysmal subarachnoid hemorrhage (SAH) remains a leading cause of death and disability after aneurysm rupture. Decreased availability of nitric oxide (NO) may be crucial in its pathogenesis. We hypothesized that endothelial NO synthase (eNOS) polymorphisms may determine susceptibility to vasospasm in SAHpatients. METHODS: We conducted a prospective cohort study of SAHpatients and determined vasospasm by cerebral angiography. We genotyped 3 eNOS polymorphisms: an intron 4 variable-number tandem-repeat, a promoter single-nucleotide polymorphism (-786T-->C SNP), and a coding SNP in exon 7 (894G-->T encoding E298D). Using multivariable logistic regression, we quantified the association of eNOS polymorphisms in patients with vasospasm confirmed by cerebral angiography. RESULTS: For the eNOS promoter -786T-->C SNP, the presence of the CC genotype compared with any T genotype (CT or TT) was associated with increased odds of vasospasm (odds ratio=2.97, 95% CI=1.32 to 6.67, P=0.008). No association with vasospasm was observed for the eNOS 894G-->T or variable-number tandem-repeat polymorphisms. CONCLUSIONS: These findings suggest that genetic variation influencing NO regulation contributes to the risk of angiographic vasospasm in patients with SAH. The specific role of the promoter SNP (-786T-->C) may determine the effect of NO regulated by this pathway, distinct from other known eNOS polymorphisms.
Authors: G Lanzino; N F Kassell; N W Dorsch; A Pasqualin; L Brandt; P Schmiedek; L L Truskowski; W M Alves Journal: J Neurosurg Date: 1999-06 Impact factor: 5.115
Authors: M Nakayama; H Yasue; M Yoshimura; Y Shimasaki; K Kugiyama; H Ogawa; T Motoyama; Y Saito; Y Ogawa; Y Miyamoto; K Nakao Journal: Circulation Date: 1999-06-08 Impact factor: 29.690
Authors: M Yoshimura; H Yasue; M Nakayama; Y Shimasaki; H Ogawa; K Kugiyama; Y Saito; Y Miyamoto; Y Ogawa; T Kaneshige; H Hiramatsu; T Yoshioka; S Kamitani; H Teraoka; K Nakao Journal: J Investig Med Date: 2000-09 Impact factor: 2.895
Authors: Peter Vajkoczy; Bernhard Meyer; Stefan Weidauer; Andreas Raabe; Claudius Thome; Florian Ringel; Volker Breu; Peter Schmiedek Journal: J Neurosurg Date: 2005-07 Impact factor: 5.115
Authors: G S Allen; H S Ahn; T J Preziosi; R Battye; S C Boone; S C Boone; S N Chou; D L Kelly; B K Weir; R A Crabbe; P J Lavik; S B Rosenbloom; F C Dorsey; C R Ingram; D E Mellits; L A Bertsch; D P Boisvert; M B Hundley; R K Johnson; J A Strom; C R Transou Journal: N Engl J Med Date: 1983-03-17 Impact factor: 91.245
Authors: K A Popugaev; I A Savin; A U Lubnin; A S Goriachev; B A Kadashev; P L Kalinin; I N Pronin; A V Oshorov; M A Kutin Journal: Neurol Sci Date: 2011-02-03 Impact factor: 3.307
Authors: Henrik Rueffert; Anja Gumplinger; Christof Renner; Markus Dengl; Andreas Reske; Udo X Kaisers; Jürgen Meixensberger Journal: Neurocrit Care Date: 2011-12 Impact factor: 3.210
Authors: Claudia S Robertson; Shankar P Gopinath; Alex B Valadka; Mai Van; Paul R Swank; J Clay Goodman Journal: J Neurotrauma Date: 2011-05-04 Impact factor: 5.269
Authors: Tatiana Foroud; Daniel L Koller; Dongbing Lai; Laura Sauerbeck; Craig Anderson; Nerissa Ko; Ranjan Deka; Thomas H Mosley; Myriam Fornage; Daniel Woo; Charles J Moomaw; Richard Hornung; John Huston; Irene Meissner; Joan E Bailey-Wilson; Carl Langefeld; Guy Rouleau; E Sander Connolly; Bradford B Worrall; Dawn Kleindorfer; Matthew L Flaherty; Sharyl Martini; Jason Mackey; Felipe De Los Rios La Rosa; Robert D Brown; Joseph P Broderick Journal: Stroke Date: 2012-09-06 Impact factor: 7.914
Authors: Andrew F Ducruet; Paul R Gigante; Zachary L Hickman; Brad E Zacharia; Eric J Arias; Bartosz T Grobelny; Justin W Gorski; Stephan A Mayer; E Sander Connolly Journal: J Cereb Blood Flow Metab Date: 2010-01-13 Impact factor: 6.200
Authors: Hyungsuk Kim; Elizabeth Crago; Mirim Kim; Paula Sherwood; Yvette Conley; Samuel Poloyac; Mary Kerr Journal: Int J Stroke Date: 2012-05-09 Impact factor: 5.266